Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity

Molecular and Cellular Neuroscience

Volumn 59, Issue , 2014, Pages 10-23

  Krishnan, Gopinath ^a,b   Chatterjee, Nivedita ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b SASTRA UNIVERSITY   (India)

Author keywords

Endocannabinoids; HIV1 Tat; Muller glia; Retina

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; ENDOCANNABINOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1 BINDING PROTEIN 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; TRANSACTIVATOR PROTEIN; TRISTETRAPROLIN; UNCLASSIFIED DRUG; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; AMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR AGONIST; CYTOKINE; DUSP1 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TAB2 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLAMMATION; INNATE IMMUNITY; MUELLER CELL; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; ADULT; AGED; CELL CULTURE; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MACROGLIA; METABOLISM; MIDDLE AGED; TOXICITY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; ARACHIDONIC ACIDS; CANNABINOID RECEPTOR AGONISTS; CELLS, CULTURED; CYTOKINES; DUAL SPECIFICITY PHOSPHATASE 1; ENDOCANNABINOIDS; EPENDYMOGLIAL CELLS; GLYCERIDES; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; NF-KAPPA B; POLYUNSATURATED ALKAMIDES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRISTETRAPROLIN;

EID: 84893071817     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2014.01.001     Document Type: Article

References (61)

1. Bethel-Brown C., Yao H., Hu G., Buch S. Platelet-derived growth factor (PDGF)-BB-mediated induction of monocyte chemoattractant protein 1 in human astrocytes: implications for HIV-associated neuroinflammation. J. Neuroinflammation 2012, 1:262.
2. Bhattacharyya S., Sen P., Wallet M., Long B., Baldwin A.S., Tisch R. Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IkappaB kinase activity. Blood 2004, 104:1100-1109.
3. Boeuf P., Vigan-Womas I., Jublot D., Loizon S., Barale J.C., Akanmori B.D., Mercereau-Puijalon O., Behr C. CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol. 2005, 4:5.
4. Bosier B., Muccioli G.G., Hermans E., Lambert D.M. Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. Biochem. Pharmacol. 2010, 80:1-12.
5. Boulares A.H., Yakovlev A.G., Ivanova V., Stoica B.A., Wang G., Iyer S., Smulson M. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J. Biol. Chem. 1999, 274:22932-22940.
6. Brahmachari S., Fung Y.K., Pahan K. Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J. Neurosci. 2006, 26:4930-4939.
7. Bridges D., Ahmad K., Rice A.S. The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Br. J. Pharmacol. 2001, 133:586-594.
8. Cao S., Zhang X., Edwards J.P., Mosser D.M. NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J. Biol. Chem. 2006, 281:26041-26050.
9. Carballo E., Lai W.S., Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998, 281:1001-1005.
10. Chatterjee N., Callen S., Seigel G.M., Buch S.J. HIV-1 Tat-mediated neurotoxicity in retinal cells. J. Neuroimmune Pharmacol. 2011, 6:399-408.
11. Chi H., Barry S.P., Roth R.J., Wu J.J., Jones E.A., Bennett A.M., Flavell R.A. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2274-2279.
12. Clarke D.L., Clifford R.L., Jindarat S., Proud D., Pang L., Belvisi M., Knox A.J. TNFα and IFNγ synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-κB, and the transcriptional coactivator CREB-binding protein. J. Biol. Chem. 2010, 285:29101-29110.
13. Conner J.R., Smirnova I.I., Moseman A.P., Poltorak A. IRAK1BP1 inhibits inflammation by promoting nuclear translocation of NF-kappaB p50. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11477-11482.
14. Correa F., Hernangómez M., Mestre L., Loría F., Spagnolo A., Docagne F., Di Marzo V., Guaza C. Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB. Glia 2010, 58(2):135-147.
15. Croitoru-Lamoury J., Guillemin G.J., Boussin F.D., Mognetti B., Gigout L.I., Chéret A., Vaslin B., Le Grand R., Brew B.J., Dormont D. Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 2003, 41:354-370.
16. Docagne F., Muñetón V., Clemente D., Ali C., Loría F., Correa F., Hernangómez M., Mestre L., Vivien D., Guaza C. Excitotoxicity in a chronic model of multiple sclerosis: neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation. Mol. Cell. Neurosci. 2007, 34(4):551-561. (Apr, Epub 2007 Jan 16).
17. Eljaschewitsch E., Witting A., Mawrin C., Lee T., Schmidt P.M., Wolf S., Hoertnagl H., Raine C.S., Schneider-Stock R., Nitsch R., Ullrich O. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 2006, 49:67-79.
18. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., Wingfield P., Gallo R.C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 1993, 67:277-287.
19. Esposito G., Ligresti A., Izzo A.A., Bisogno T., Ruvo M., Di Rosa M., Di Marzo V., Iuvone T. The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation. J. Biol. Chem. 2002, 277:50348-50354.
20. Glass J.D., Fedor H., Wesselingh S.L., McArthur J.C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 1995, 38:755-762.
21. Gober M.D., Fishelevich R., Zhao Y., Unutmaz D., Gaspari A.A. Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis. J. Invest. Dermatol. 2008, 128:1460-1469.
22. González-Scarano F., Martín-García J. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 2005, 5:69-81.
23. Hall J.C., Hall B.J., Cockerell C.J. HIV/AIDS in the post-HAART era: manifestations, treatment, and epidemiology. The Immune Reconstitution Inflammatory Syndrome 2011, Peoples Medical Publishing House, USA, Connecticut. D.M. Murdoch, W.D.F. Vener, C. Feldman (Eds.).
24. Han K.H., Lim S., Ryu J., Lee C.W., Kim Y., Kang J.H., Kang S.S., Ahn Y.K., Park C.S., Kim J.J. CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages. Cardiovasc. Res. 2009, 84:378-386.
25. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:1932-1936.
26. Hirotani T., Lee P.Y., Kuwata H., Yamamoto M., Matsumoto M., Kawase I., Akira S., Takeda K. The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J. Immunol. 2005, 174:3650-3657.
27. Holland G.N. AIDS and ophthalmology: the first quarter century. Am J. Ophthalmol. 2008, 145:397-408.
28. Hong S., Lim S., Li A.G., Lee C., Lee Y.S., Lee E.K., Park S.H., Wang X.J., Kim S.J. Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat. Immunol. 2007, 8:504-513.
29. Horváth B., Mukhopadhyay P., Haskó G., Pacher P. The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. Am. J. Pathol. 2012, 180:432-442.
30. Huang X.X., Yamashiki M., Nakatani K., Nobori T., Mase A. Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system. J. Clin. Lab. Anal. 2001, 15:199-209.
31. Jing Q., Huang S., Guth S., Zarubin T., Motoyama A., Chen J., Di Padova F., Lin S.C., Gram H., Han J. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 2005, 120:623-634.
32. Johnson T.V., Martin K.R. Development and characterization of an adult retinal explant organotypic tissue culture system as an in vitro intraocular stem cell transplantation model. Invest. Ophthalmol. Vis. Sci. 2008, 49:3503-3512.
33. Kamada S., Kikkawa U., Tsujimoto Y., Hunter T. Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein(s). J. Biol. Chem. 2005, 280:857-860.
34. Kanayama A., Seth R.B., Sun L., Ea C.K., Hong M., Shaito A., Chiu Y.H., Deng L., Chen Z.J. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol. Cell 2004, 15:535-548.
35. Knecht D.A., Dimond R.L. Visualization of antigenic proteins on Western blots. Anal. Biochem. 1984, 136:180-184.
36. Krishnan G., Chatterjee N. Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation. Glia 2012, 60:1629-1645.
37. Kumar A., Dhawan S., Mukhopadhyay A., Aggarwal B.B. Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. FEBS Lett. 1999, 46:140-144.
38. Lai W.S., Parker J.S., Grissom S.F., Stumpo D.J., Blackshear P.J. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol. Cell. Biol. 2006, 26:9196-9208.
39. Lambert D.M., Fowler C.J. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J. Med. Chem. 2005, 48:5059-5087.
40. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
41. Lu S.M., Tremblay M.È., King I.L., Qi J., Reynolds H.M., Marker D.F., Varrone J.J., Majewska A.K., Dewhurst S., Gelbard H.A. HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells. PLoS One 2011, 6:e23915.
42. Ma M., Nath A. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J. Virol. 1997, 71:2495-2499.
43. Malfait A.M., Gallily R., Sumariwalla P.F., Malik A.S., Andreakos E., Mechoulam R., Feldmann M. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:9561-9566.
44. McCluskey P.J. HIV-related eye disease. Med. J. Aust. 1993, 158:111-113.
45. McGillem G.S., Guidry C., Dacheux R.F. Antigenic changes of rabbit retinal Müller cells in culture. Invest. Ophthalmol. Vis. Sci. 1998, 39:1453-1461.
46. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 2001, 1:135-145.
47. Miller R.J., Meucci O. AIDS and the brain: is there a chemokine connection?. Trends Neurosci. 1999, 22:471-479.
48. Nucci C., Bari M., Spanò A., Corasaniti M., Bagetta G., Maccarrone M., Morrone L.A. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection. Prog. Brain Res. 2008, 173:451-464.
49. Rochira J.A., Matluk N.N., Adams T.L., Karaczyn A.A., Oxburgh L., Hess S.T., Verdi J.M. A small peptide modeled after the NRAGE repeat domain inhibits XIAP-TAB1-TAK1 signaling for NF-κB activation and apoptosis in P19 cells. PLoS One 2011, 6:e20659.
50. Sawa Y., Ueki T., Hata M., Iwasawa K., Tsuruga E., Kojima H., Ishikawa H., Yoshida S. LPS-induced IL-6, IL-8, VCAM-1, and ICAM-1 expression in human lymphatic endothelium. J. Histochem. Cytochem. 2008, 56:97-109.
51. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
52. Shah A., Kumar A. HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-κB pathway and can be silenced by gp120-specific siRNA. J. Neuroinflammation 2010, 29:96.
53. Shah A., Verma A.S., Patel K.H., Noel R., Rivera-Amill V., Silverstein P.S., Chaudhary S., Bhat H.K., Stamatatos L., Singh D.P., Buch S., Kumar A. HIV-1 gp120 induces expression of IL-6 through a nuclear factor-kappa B-dependent mechanism: suppression by gp120 specific small interfering RNA. PLoS One 2011, 6:e21261.
54. Shamsuddin N., Kumar A. TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus. J. Immunol. 2011, 186:7089-7097.
55. Trazzi S., Steger M., Mitrugno V.M., Bartesaghi R., Ciani E. CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/glycogen synthase kinase-3beta/beta-catenin signaling. J. Biol. Chem. 2010, 285:10098-10109.
56. Venkatesh K.K., Biswas J., Kumarasamy N. Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus/acquired immune deficiency syndrome. Indian J. Ophthalmol. 2008, 56:391-393.
57. Walter L., Stella N. Cannabinoids and neuroinflammation. Br. J. Pharmacol. 2004, 141:775-785.
58. Williams R., Dhillon N.K., Hegde S.T., Yao H., Peng F., Callen S., Chebloune Y., Davis R.L., Buch S.J. Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes. Glia 2009, 57:734-743.
59. Williams R., Yao H., Dhillon N.K., Buch S.J. HIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes. PLoS One 2009, 28:e5709.
60. Yazulla S. Endocannabinoids in the retina: from marijuana to neuroprotection. Prog. Retin. Eye Res. 2008, 27:501-526.
61. Zhou B.Y., Liu Y., Bo Kim, Xiao Y., He J.J. Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Mol. Cell. Neurosci. 2004, 27(3):296-305. (Nov).